Last week, Warwick Ventures played host to the first Midlands ICURe (Innovation to Commercialisation of University Research) bootcamp, welcoming 12 entrepreneurial teams from eight universities to Warwick Conferences to develop their commercially-promising ideas.
This year's University awards saw a joint win to the Chemistry Department and Warwick Ventures in the Research Contribution category for the creation of spin-out Interface Polymers. Each year the awards recognise outstanding contribution of staff at Warwick across all departments.
An independent survey of over 500 chatbot owners and developers by text analytics specialists Warwick Analytics reveals the majority are not satisfied with the performance of their chatbots and say human validation is key. The research shows that 59% of businesses who have a chatbot are unsatisfied with its performance.
Warwick Ventures is pleased to announce the awardees of the first round of the Ideas Fund, which is aimed at supporting the Arts, Humanities and Social Sciences faculties in applying their research and innovation to benefit the wider society.
Warwick joins university partnership to launch Midlands Innovation Commercialisation of Research Accelerator (MICRA)
The University of Warwick is part of a new connected system of technology transfer offices that has been launched to drive jobs and economic growth across the Midlands region, following a £5million award from Research England.
An £8 million expansion of the Innovation to Commercialisation of University Research (ICURe) pilot programme will allow even more commercially-promising ideas to get to market more quickly. The funding will see the University of Warwick and Queen’s University Belfast join the programme, which is supported by Innovate UK, part of the new national funding body UK Research and Innovation.
Recycling Technologies, a company specialising in the chemical recycling of mixed plastic waste and based upon research originating at the University of Warwick, has raised £3.7m in new investment including a major strategic £1m equity investment from global energy trader, InterChem to support its operations and acquire a new facility.
Medherant Ltd, a leader in next-generation transdermal drug delivery, is pleased to announce the appointment of a new senior executive, David Davies, as Head of Development. This appointment marks a significant expansion of the Company’s management team to support the business as it moves into clinical development of its ibuprofen TEPI Patch®.
Warwick Ventures is piloting a new mentoring scheme to match experienced business professionals with early career researchers to help coach the researchers and encourage them in viewing their ideas through a commercial lens.
VirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has won non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA).